Progyny Inc is a benefits management company specializing in fertility, family building, and women's health benefits solutions... Show more
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where PGNY advanced for three days, in of 326 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for PGNY just turned positive on June 27, 2025. Looking at past instances where PGNY's MACD turned positive, the stock continued to rise in of 49 cases over the following month. The odds of a continued upward trend are .
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 60 cases where PGNY's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .
The Momentum Indicator moved below the 0 level on July 02, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on PGNY as a result. In of 83 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
PGNY moved below its 50-day moving average on July 02, 2025 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where PGNY declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
PGNY broke above its upper Bollinger Band on June 10, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a medical device company, which engages in the field of reproductive medicine, translating scientific discoveries related to early embryo development into clinical tools